Test directory: Phosphatidylserine Antibody Panel

Ordering Code7814
Test NamePhosphatidylserine Antibody Panel
AliasPhosphatidylserine IgG, IgM, IgA Ab
Anti-phosphatidylserine Antibodies
aPS Antibodies
Preferred SpecimenSerum
Preferred ContainerSST (Gold)
Optimum Volume1 mL
Transport RequirementsOahu: Ambient
Airline: Refrigerated
Specimen StabilityAmbient: 2 Days
Refrigerated: 2 Weeks
Frozen: 1 Month
Rejection CriteriaHemolyzed, Heat-inactivated, Grossly lipemic
Avail. StatNO
Analytic Time7 Days
MethodologySemi-Quantitative Enzyme-Linked Immunosorbent Assay
Reference Lab ARUP Laboratories

Reference range(s)

The reference ranges listed below are valid on this date of April 28, 2024.
ComponentAgeMale NormMale Critical LowMale Critical HighFemale NormFemale Critical HighFemale Critical LowUnitsAdd'l info
Phosphatidylserine Antibody IgGALL0-150-15GPS

IgG and/or IgM...
IgG and/or IgM antibodies to phosphatidylserine (aPS) may be associated with a positive test for anti-cardiolipin autoantibodies (aCL) and risk for obstetric antiphospholipid syndrome (APS)
Strong clinical correlation is recommended in the absence of lupus anticoagulant, IgG and/or
IgM cardiolipin and/or beta2 glycoprotein antibodies

Isolated presence of IgM or IgG antibodies to aPS may have questionable clinical significance for APS and/or SLE

If results are positive, repeat testing with two or more specimens drawn at least 12 weeks apart to demonstrate persistence of antibodies

Results should not be used alone for diagnosis and must be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests
Note1
Phosphatidylserine Antibody IgMALL0-210-21MPS
Phosphatidylserine Antibody IgAALL0-190-19APS

Note1:


IgG and/or IgM antibodies to phosphatidylserine (aPS) may be associated with a positive test for anti-cardiolipin autoantibodies (aCL) and risk for obstetric antiphospholipid syndrome (APS)
Strong clinical correlation is recommended in the absence of lupus anticoagulant, IgG and/or
IgM cardiolipin and/or beta2 glycoprotein antibodies

Isolated presence of IgM or IgG antibodies to aPS may have questionable clinical significance for APS and/or SLE

If results are positive, repeat testing with two or more specimens drawn at least 12 weeks apart to demonstrate persistence of antibodies

Results should not be used alone for diagnosis and must be interpreted in light of APS-specific clinical manifestations and/or other criteria phospholipid antibody tests
.